A bibliometric analysis of research on heart failure comorbid with depression from 2002 to 2021

Hangfeng Ying1, Xinying Zhang2, Teng He2

  • 1Department of Cardiology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, Jiangsu, China.

Heliyon
|February 9, 2023
PubMed

Insights

This bibliometric analysis maps research on heart failure (HF) and depression, identifying key trends and knowledge gaps. Future research should prioritize understanding HF-depression comorbidity mechanisms and developing effective interventions.

Area of Science:

  • Cardiology
  • Psychiatry
  • Bibliometrics

Background:

  • Heart failure (HF) and depression frequently coexist, negatively impacting patient outcomes and quality of life.
  • Despite extensive research, bibliometric analyses of HF with comorbid depression are scarce.

Purpose of the Study:

  • To analyze the development, research hotspots, and future directions of studies on HF comorbid with depression.
  • To provide a comprehensive overview of the scientific landscape concerning this comorbidity.

Main Methods:

  • Bibliometric analysis of publications from January 2002 to December 2021 using CiteSpace and VOSviewer.
  • Co-occurrence, burst, and timeline analyses of keywords; co-citation analysis of literature.
  • Visualization of cooperative networks among countries, authors, and institutions.

Main Results:

  • Mapping of global research collaboration, influential authors, and institutions in the field.
  • Identification of key research themes, emerging trends, and significant shifts over time.
  • Highlighting foundational studies through co-citation analysis.

Conclusions:

  • The study provides a structured overview of HF with depression research.
  • Emphasizes the need for future research focused on elucidating comorbidity mechanisms.
  • Recommends prioritizing the development of more effective interventions for this patient population.

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
412
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
20
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
31
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
31